Antihypertensive drugs reduced risk for new-onset type 2 diabetes; effect varies by antihypertensive class

ACP Journal ClubApril 2022Antihypertensive drugs reduced risk for new-onset type 2 diabetes; effect varies by antihypertensive classMichael Tanner, MDMichael Tanner, MDNYU Grossman School of Medicine, New York, New York, USA (M.T.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/J22-0018 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Source CitationNazarzadeh M, Bidel Z, Canoy D, et al. Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis. Lancet. 2021;398:1803-10. https://pubmed.ncbi.nlm.nih.gov/34774144Clinical Impact RatingsGIM/FP/GP: Cardiology: Endocrinology: References1. New York State Department of Health. Prediabetes. Accessed at https://health.ny.gov/diseases/conditions/diabetes/prediabetes/ on 10 Feb 2022. Google Scholar2. Centers for Disease Control and Prevention. Facts about hypertension. Accessed at www.cdc.gov/bloodpressure/facts.htm on 10 Feb 2022. Google Scholar3. Centers for Disease Control and Prevention. Prevalence of prediabetes among adults. Accessed at www.cdc.gov/diabetes/data/statistics-report/prevalence-of-prediabetes.html on 10 Feb 2022. Google Scholar4. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021-104. [PMID: 30165516] Google Scholar5. Eleftheriadou I, Tsioufis C, Tsiachris D, et al. Choice of antihypertensive treatment in subjects with pre-diabetes. Is there a dream after the navigator. Curr Vasc Pharmacol. 2011;9:715-22. [PMID: 21470107] Google Scholar Author, Article, and Disclosure InformationAffiliations: NYU Grossman School of Medicine, New York, New York, USA (M.T.)Disclosures: The commentator has reported no disclosures of interest. The form can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=J22-0018.This article was published at Annals.org on 05 April 2022. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics April 2022Volume 175, Issue 4Page: JC44KeywordsACE inhibitorsBlood pressureClinical trialsDisclosureDrugsHbA1cHypertensionNetwork analysisSystolic pressureType 2 diabetes ePublished: 5 April 2022 Issue Published: April 2022 Copyright & PermissionsCopyright © 2022 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...